The clinical development program was discontinued after reaching phase II trials
Neurofibromatosis: phenotype, natural history, and pathogenesis
Abstract GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs
Summary AOD-9604 is a synthetic peptide fragment derived from human growth hormone (HGH) that mimics the fat-burning effects of HGH without its associated side effects, AOD-9604 is a targeted therapy for weight management, metabolic optimization, and joint health
The available human evidence is limited to early phase-2 studies on postoperative ileus, as reported by Beck et al., 2014, and has not led to any authorisation
GHK-Cu's efficacy in anti-inflammatory and collagen synthesis processes